Severity and Risk of Death Due to COVID 19
DOI:
https://doi.org/10.32947/ajps.v20i4.769Abstract
A novel SARS-CoV2 virus appeared since December 2019 and triggering the Corona virus disease (2019-nCoV or COVID-19). Usually the symptoms begin as mild, with only fever, cough, and occasional dyspnea. The severe symptoms such as
pneumonitis, and acute respiratory distress syndrome (ARDS), may occur 5-8 days into COVID-19 illness in a minority of patients. Method: for this narrative review, more than 25 related scientific articles and reports about COVID- 19 were used from different databases (e.g., PubMed, Google Scholar, and Web of Science) using keywords such as SARS-CoV2, COVID-19, Mortality, and CO-morbidities. Results The results of this review reported that aged people are more vulnerable to severe pattern of COVID-19 disease than people younger than 50 years; probably because of health issues and comorbidities in that population group. Male more than female affected by COVID-19. On the other hand, children might be less probable to infected or might show mild symptoms if infected. The small percentage of current smokers infected with COVID-19 compared with the actual percentage of smokers (50·5%) in China are unlikely to be related with the incidence, severity, or mortality rate of COVID-19. The poorer clinical outcome in COVID-19 infected patients may have related to the presence and number of co morbidities especially hypertension, diabetes and cardiovascular diseases. The direct SARS-COV2 infection of liver cells might be the cause of liver damage but might be related to other reasons such as systemic inflammation and drug toxicity. The data suggested that liver damage is more predominant in severe cases especially with pre-existing liver diseases. patients with cancer might be more prone to COVID 19 due to their immunocompromised status but whether or not they have high risk of poor prognoses and sever event not fully established.
References
- Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology, 4th edn. Washington: ASM Press, 2016. DOI: https://doi.org/10.1128/9781555819439
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003 May 15; 348(20):1953-66. DOI: https://doi.org/10.1056/NEJMoa030781
- Kuiken T, Fouchier RAM, Schutten M, Rimmelzwaan GF, Van Amerongen G, van Riel D et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003 Jul 26; 362(9380): 263–70. DOI: https://doi.org/10.1016/S0140-6736(03)13967-0
- Drosten C, Gunther S, Preiser W, Van Der Werf S, Brodt HR, Becker S et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 May 15; 348(20):1967-76. DOI: https://doi.org/10.1056/NEJMoa030747
- De Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013 Jul 15; 87(14):7790-2. DOI: https://doi.org/10.1128/JVI.01244-13
- Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov 8; 367(19):1814-20. DOI: https://doi.org/10.1056/NEJMoa1211721
- WHO? Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Dec 31, 2003.
- WHO? WHO MERS global summary and assessment of risk, July, 2019.
- Jiang X, Coffee M, Bari A, Wang J, Jiang X, Huang J, et al. Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. CMC.2020; 63 (1): 537-551. DOI: https://doi.org/10.32604/cmc.2020.010691
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497–506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 7 Feb 2020; 323(11):1061-1069. DOI: https://doi.org/10.1001/jama.2020.1585
- Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 19 Feb 2020; 368: m606. DOI: https://doi.org/10.1136/bmj.m606
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 28 Feb 2020:1-113.
- Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 1 Sep 2013; 13(9): 752–761. DOI: https://doi.org/10.1016/S1473-3099(13)70204-4
- Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to person transmission: a study of a family cluster. Lancet. Feb 2020; 395(10223): 514–523. DOI: https://doi.org/10.1016/S0140-6736(20)30154-9
- WHO? Coronavirus disease 2019 (COVID-19). Situation Report—41. 1 March, 2020.
- Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 12 Mar 2020; pii: S1473-3099(20)30195-X. DOI: https://doi.org/10.1016/S1473-3099(20)30195-X
- Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 6 Feb 2020; 25(5): 2000062. DOI: https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062
- WHO? Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Feb, 2020.
- Mizumoto K, Chowell G. Estimating the risk of 2019 novel coronavirus death during the course of the outbreak in China, 2020. medRxiv. 28 Mar 2020. DOI: https://doi.org/10.1101/2020.02.19.20025163
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 28 Mar 2020; 395(10229):1054-1062. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
- Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Res Med. 24 Feb 2020; pii: S2213-2600(20)30079-5. DOI: https://doi.org/10.1016/S2213-2600(20)30079-5
- Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 16 Jul 2003; 290(3):367-73. DOI: https://doi.org/10.1001/jama.290.3.367
- Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 16 Jul 2003; 290(3):374-380. DOI: https://doi.org/10.1001/jama.290.3.374
- Gomersall CD, Joynt GM, Lam P, Li T, Yap F, Lam D, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med. 1 Mar 2004; 30 (3): 381–87. DOI: https://doi.org/10.1007/s00134-003-2143-y
- Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med.18Mar 2014; 160 (6):389-397. DOI: https://doi.org/10.7326/M13-2486
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study. Lancet. 15 Feb 2020; 395(10223):507–513. DOI: https://doi.org/10.1016/S0140-6736(20)30211-7
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 23 Mar 2020. DOI: https://doi.org/10.1001/jama.2020.4683
- Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 27 Mar 2020; pii: S1473-3099(20)30200-0. DOI: https://doi.org/10.1016/S1473-3099(20)30200-0
- Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. medRxiv. 1 Jan 2020. DOI: https://doi.org/10.1101/2020.02.23.20026864
- Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 4 Nov 2003; 139(9):715-723. DOI: https://doi.org/10.7326/0003-4819-139-9-200311040-00005
- Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 1 Mar 2018; 73(3):286-289. DOI: https://doi.org/10.1136/thoraxjnl-2016-209313
- Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 19 Feb 2020; 00:1–12. DOI: https://doi.org/10.1111/all.14238
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 26 Mar 2020; 382(13):1199-1207. DOI: https://doi.org/10.1056/NEJMoa2001316
- Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 17 Mar 2020; 395(10229):1039-1046. DOI: https://doi.org/10.1016/S0140-6736(20)30528-6
- de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. Aug 2016; 14 (8): 523–534. DOI: https://doi.org/10.1038/nrmicro.2016.81
- Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 23 Feb 2016; 315 (8): 788–800. DOI: https://doi.org/10.1001/jama.2016.0291
- Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 4 Jun 2003; 289 (21):2801-2809. DOI: https://doi.org/10.1001/jama.289.21.JOC30885
- Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 1 Apr 2020; 8 (4):420-2. DOI: https://doi.org/10.1016/S2213-2600(20)30076-X
- Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 1 Jan 2020. DOI: https://doi.org/10.20944/preprints202002.0051.v3
- Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 1 May 2020; 5(5):426-428. DOI: https://doi.org/10.1016/S2468-1253(20)30076-5
- Hu S, Gao R, Liu L, Zhu M, Wang W, Wang Y, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circ J. Mar 2019; 34:209-220.
- Liu M, Liu SW, Wang LJ, Bai YM, Zeng XY, Guo HB, et al. Burden of diabetes, hyperglycemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 1 Jun 2019; 45 (3):286-293. DOI: https://doi.org/10.1016/j.diabet.2018.08.008
- Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. May 2020; 5(5):428-430. DOI: https://doi.org/10.1016/S2468-1253(20)30057-1
- Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. Feb 2004; 39 (2): 302–310. DOI: https://doi.org/10.1002/hep.20111
- Alsaad KO, Hajeer AH, Al Balwi M, Al Moaiqel M, Al Oudah N, Al Ajlan A, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection—clinicopathological and ultrastructural study. Histopathology. Feb 2018; 72 (3): 516–524. DOI: https://doi.org/10.1111/his.13379
- Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. Apr 2020; 20(4):425-434. DOI: https://doi.org/10.1016/S1473-3099(20)30086-4
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. Mar 2020; 21(3):335-337. DOI: https://doi.org/10.1016/S1470-2045(20)30096-6
- Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. Apr 2020 Apr; 21(4): e180. DOI: https://doi.org/10.1016/S1470-2045(20)30150-9
Downloads
Published
How to Cite
Issue
Section
License
